(Q84805365)
Statements
First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study (English)
Makoto Maemondo
Yuji Minegishi
Akira Inoue
Kunihiko Kobayashi
Masao Harada
Shoji Okinaga
Naoto Morikawa
Satoshi Oizumi
Tomoaki Tanaka
Hiroshi Isobe
Shoji Kudoh
Koichi Hagiwara
Toshihiro Nukiwa
1 September 2012